HPV Testing & Cervical Cancer Screening: A Complete Guide to Molecular Diagnostics June 23, 2026 IVD Insights HPV Testing & Cervical Cancer Screening: A Complete Guide to Molecular Diagnostics Read Post »
2024 China AIDS Diagnosis & Treatment Guidelines June 15, 2026 IVD Insights 2024 China AIDS Diagnosis & Treatment Guidelines Read Post »
An Early Screening Solution for Acute Myocardial Infarction (AMI) June 9, 2026 IVD Insights An Early Screening Solution for Acute Myocardial Infarction (AMI) Read Post »
HIV-1 Management | High-Sensitivity HIV-1 Viral Load Quantitative NAT Assay June 3, 2026 IVD Insights HIV-1 Management | High-Sensitivity HIV-1 Viral Load Quantitative NAT Assay Read Post »
Virtue Diagnostics & Labtest: IVD Innovations at Hospitalar 2026 May 27, 2026 Virtuedx News Virtue Diagnostics & Labtest: IVD Innovations at Hospitalar 2026 Read Post »
Johnson Zhang: the leader behind the transformation of Virtue Diagnostics Group and the new era of Labtest May 19, 2026 Virtuedx News Johnson Zhang: the leader behind the transformation of Virtue Diagnostics Group and the new era of Labtest Read Post »
Pre-NAT II | High-Sensitivity HCV RNA Quantitative Nucleic Acid Testing May 12, 2026 IVD Insights Pre-NAT II | High-Sensitivity HCV RNA Quantitative Nucleic Acid Testing Read Post »
SUPERFLEX POCT Chemiluminescence Immunoassay Platform: High-Sensitivity Cardiac Troponin (hs-cTn) May 6, 2026 IVD Insights SUPERFLEX POCT Chemiluminescence Immunoassay Platform: High-Sensitivity Cardiac Troponin (hs-cTn) Read Post »
